Epstein Secrets

BioNTech." In a 2,700-word article, the New York Times <https://www.nytimes.com/2020/11/30/health/coronavirus- vaccines-treatments.html> (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at han

ith a greater proportion of residents at high risk." The New York Times <https://www.nytimes.com/live/2020/11/30/world/covid-19-coronavirus> (11/30, Grady, Zraick, 18.61M) reports that on Monday, when "asked about the role of states in the distribution process," Azar "said that doses would be shipped

hose of another candidate that is about a week ahead from Pfizer and German firm BioNTech." In a 2,700-word article, the New York Times (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at ha

based on states' total populations, forcing hard choices in states with a greater proportion of residents at high risk." The New York Times (11/30, Grady, Zraick, 18.61M) reports that on Monday, when "asked about the role of states in the distribution process," Azar "said that doses would be shipped o

hose of another candidate that is about a week ahead from Pfizer and German firm BioNTech." In a 2,700-word article, the New York Times (11/30, Al, McNeil, 18.61M) says that while "good news about vaccines or antibody treatments surfaces" every week, "offering hope that an end to the pandemic is at ha

based on states' total populations, forcing hard choices in states with a greater proportion of residents at high risk." The New York Times (11/30, Grady, Zraick, 18.61M) reports that on Monday, when "asked about the role of states in the distribution process," Azar "said that doses would be shipped o